C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1999
12/01/1999	EP0960941A1 Gene Therapy for cell proliferative diseases
12/01/1999	EP0960936A1 Reconstituted human anti-hm1.24 antibody
12/01/1999	EP0960339A1 Assay for collagen type ii fragments
12/01/1999	EP0960338A1 Diagnostic methods and compositions based on the distribution of rad51
12/01/1999	EP0960337A1 Cathepsin K and breast cancer
12/01/1999	EP0960336A1 Peptide reagent for the detection of human cytomegalovirus (cmv)
12/01/1999	EP0960334A1 Vegf-b/receptor complex and uses thereof
12/01/1999	EP0960212A1 Gene identification method
12/01/1999	EP0960208A1 Glutathione s-transferase (gst) genes in cancer
12/01/1999	EP0960203A1 Mammalian chk1 effector cell-cycle checkpoint protein kinase materials and methods
12/01/1999	EP0960196A1 Novel receptor that causes cell death
12/01/1999	EP0960193A1 ISOLATION AND CLONING OF THE HUMAN hARSA-I GENE AND USES THEREOF
12/01/1999	EP0960192A1 Synthetic polynucleotides
12/01/1999	EP0960120A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
12/01/1999	EP0960117A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
12/01/1999	EP0960115A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
12/01/1999	EP0960114A1 Polymorphisms and new genes in the region of the human hemochromatosis gene
12/01/1999	EP0959903A1 NOVEL FabD
12/01/1999	EP0959899A1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
12/01/1999	EP0959896A2 Human thyrotropin receptor compositions and use thereof
12/01/1999	EP0959895A1 Peptides responsive to antibodies against a consensus peptide of the cs4-cfa/i family proteins
12/01/1999	EP0763128B1 Method for producing heterologous bispecific antibodies
12/01/1999	EP0755517B1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
12/01/1999	CN1236647A Pigment mark poly-antibody and its preparing process
11/1999
11/30/1999	US5994627 Genetic sequences conferring nematode resistance in plants and uses therefor
11/30/1999	US5994524 Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same
11/30/1999	US5994523 A nucleic acid molecule encoding a peptide comprising a sequence consisting of 8 contiguous amino acids of th mart-1(melanoma antigen recognized by t-cell-1) a preferential amino acid sequence which is capable of reacting tumor
11/30/1999	US5994519 Labelling proteins, peptides, or ligands by binding first marker ligand-enzyme conjugate to a specific binding pair member; binding label molecules to proteins, peptides, or ligands; isolating and/or purifying labelled product
11/30/1999	US5994518 Method of producing a polypeptide having human granulocyte colony stimulating factor activity
11/30/1999	US5994515 Antibodies directed against cellular coreceptors for human immunodeficiency virus and methods of using the same
11/30/1999	US5994514 Differential binding fc epsilon ri antagonist ige polypeptide
11/30/1999	US5994513 Oncoprotein protein kinase
11/30/1999	US5994512 Antibody derivatives for controlling gene expression
11/30/1999	US5994511 Anti-IgE antibodies and methods of improving polypeptides
11/30/1999	US5994510 Recombinant antibodies specific for TNFα
11/30/1999	US5994505 Forms of class II MHC transactivator (CIITA)
11/30/1999	US5994504 Vitamin D response element binding protein
11/30/1999	US5994306 Fine-tuned protegrins
11/30/1999	US5994304 Polypeptide
11/30/1999	US5994301 Corpuscles of stannius protein, stanniocalcin
11/30/1999	US5994131 Incubating a test compound with epithial cells that will express the human op-1 protein, which induces endochondral bone formation; measuring amount of protein expressed from cells with test compound, comparing values to control cells
11/30/1999	US5994114 A polynucleotide which codes for a protein having taxadiene synthase activity; chemotherapy
11/30/1999	US5994112 A polynucleotide which codes a protein; antiproliferative agents, anticarcinogenic agents, antiinflammatory agents
11/30/1999	US5994111 A polypeptide; treatment and diagnosis of respiratory infections, septic arthritis, cardiovascular infections, gastrointestinal infections, toxic shock syndrome; antibiotics
11/30/1999	US5994102 Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
11/30/1999	US5994101 DNA encoding gidA1 polypeptides
11/30/1999	US5994100 HAS2 splicing variant HOEFC11: a target in chronic renal failure, inflammatory diseases and myocardial ischemia
11/30/1999	US5994098 G protein coupled receptor gene; treatment of pain, diabetes, eating disorders, asthma; hypotensive/hypertensive agents; parkinson's/huntington's/cardiovascular diseases, ulcers, anticarcinogenic/antiallergens agents; osteoprosis,
11/30/1999	US5994097 Polynucleotide encoding human G-protein coupled receptor
11/30/1999	US5994096 Regulator
11/30/1999	US5994095 MTS2 gene
11/30/1999	US5994094 A bone morphogenetic protein; treatment of osteoporosis, prevent transplant rejection; wound healing agents; regeneration of bones, cartilage, connective tissue, skin, mucous membranes, epithelium and teeth
11/30/1999	US5994090 Using a phosphocholine-containing glycoglycerophospholipid from a mycoplasma as an immunogen to obtain an antibody specific to the glycoglycerophospholipid; aids therapy
11/30/1999	US5994088 Treating cells with a glycoprotein substrate from a group; reserpine, gramicidin, cyclosporine, vincristine, actinomycin d, taxol, verapamil and vinblastine; reacting cells with antibody to glycoprotein/substrate, detect increase binding
11/30/1999	US5994083 Collect serum samples from infected pateints with antibodies and a healthy individual, identify antibodies which bind antigens specific to the disease from phage library; select phages that display antigen recognized by antibody; vaccines
11/30/1999	US5994074 Determining and regulating expression of tyrosine phosphatase gene in cells, detecting messenger rna using oligonucleotide probes; regulating the cell cycle through altering the activity or levels of tyrosine phosphatases
11/30/1999	US5994060 Gro genes, proteins, and uses thereof
11/30/1999	US5993935 Capable of forming a covalent chemical bond to a nucleophilic ligand without the need for an intermediate activation step. the composite article is useful in diagnostic devices, in affinity purifications and enzyme immobilization.
11/30/1999	US5993828 Administering to the subject an effective dose of a composition comprising inactivated tumor cells having urinary tumor associated antigen on the cell surface and at least one tumor associated antigen
11/30/1999	US5993826 Relates generally to various outer membrane proteins (omps) of moraxella catarrhalis for use as targets in immunotherapy
11/30/1999	US5993818 Use of autoantibodies for tumor therapy and prophylaxis
11/30/1999	US5993817 Method to ameliorate osteolysis and metastasis
11/30/1999	US5993816 Methods to inhibit humoral immune responses, immunoglobulin production and B cell activation with 5c8-specific antibodies
11/30/1999	US5993815 Methods and compositions for inhibiting the activation of thrombin-activatable fibrinolysis inhibitor (TAFI)
11/30/1999	US5993813 Family of high affinity, modified antibodies for cancer treatment
11/30/1999	US5993812 Method of delaying the progression of an infection with the human immunodeficiency virus
11/30/1999	US5993811 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis
11/30/1999	US5993413 Intraoral administration device and system
11/30/1999	CA2128250C Insecticidally effective peptides
11/30/1999	CA1340832C Recombinant cmv neutralizing proteins
11/25/1999	WO1999060171A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999	WO1999060153A2 Novel g-protein coupled receptor
11/25/1999	WO1999060139A1 ENZYMATICALLY-ACTIVE RECOMBINANT HUMAN β-TRYPTASE AND METHOD OF MAKING SAME
11/25/1999	WO1999060133A2 Human nucleic acid methylases
11/25/1999	WO1999060132A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
11/25/1999	WO1999060131A2 Hemorrhagic enteritis virus dna sequences, proteins encoded thereby and various uses thereof
11/25/1999	WO1999060127A2 Il-17 homologous polypeptides and therapeutic uses thereof
11/25/1999	WO1999060125A2 Secreted proteins
11/25/1999	WO1999060115A2 Proteins and genes useful as tumor markers
11/25/1999	WO1999060113A1 Novel method for isolating gene
11/25/1999	WO1999060112A1 Antibodies and utilization thereof
11/25/1999	WO1999060097A1 clpX OF $i(STREPTOCOCCUS PNEUMONIAE)
11/25/1999	WO1999060025A1 Gene recombinant antibodies
11/25/1999	WO1999060024A1 Methods for amyloid removal using anti-amyloid antibodies
11/25/1999	WO1999060023A1 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
11/25/1999	WO1999060019A1 HUMAN EDG3sb GENE
11/25/1999	WO1999059636A1 Vegf activity inhibitors
11/25/1999	WO1999059633A1 Therapeutics using a bispecific anti-hla class ii invariant chain x anti-pathogen antibody
11/25/1999	WO1999059632A1 Methods and use of compositions comprising tnf-rii(p75) agonists for treating asthma and other allergic conditions
11/25/1999	WO1999059631A1 Prevention and treatment of hypergastrinemia
11/25/1999	WO1999059629A1 Humanized antibodies that recognize verotoxin ii and cell line producing same
11/25/1999	WO1999059620A1 Angiostatin receptor
11/25/1999	WO1999059618A1 Acrp30r1l, a homolog of acrp30 (30 kd adipocyte complement-related protein)
11/25/1999	WO1999059614A1 Modulation of angiogenesis and wound healing
11/25/1999	WO1999059609A2 Use of hmg proteins for the preparation of medicaments having cytotoxic activity
11/25/1999	WO1999059608A2 Osteoporosis treatment
11/25/1999	WO1999050301A3 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue
11/25/1999	WO1999048523A3 Antagonists of the inflammatory mediator oncostatin m (osm)
11/25/1999	WO1999047925A3 Methods and compositions for diagnosis of rheumatoid arthritis
11/25/1999	WO1999043832A3 Human proteinase molecules

1 ... 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 ... 1494